Aggressive Treatment in Pediatric Patients With Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Is Associated With Future Development of Type III Polyglandular Autoimmune Syndrome
October 2018
in “
BMJ Case Reports
”
Studysummary This case report describes a 6-year-old who developed autoimmune conditions including type III polyglandular autoimmune syndrome following drug-induced hypersensitivity syndrome, prompting an investigation into associated triggering factors. Our plain-language summary of this paper — not a Tressless recommendation.
The study discussed a 6-year-old boy with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) who developed type III polyglandular autoimmune syndrome (PASIII) following aggressive treatment with intravenous immunoglobulin (IVIG) and prednisolone. A literature review identified five similar cases, suggesting that while these treatments were effective short-term, they might increase the risk of long-term autoimmune issues in pediatric patients. The study recommended careful screening for autoantibodies and advised against therapies that could hasten immune recovery, potentially leading to PASIII.
